Tag

Inc.- Pagina 3

Menarini Group Shares NEXPOVIO® (selinexor) Subgroup Data from BOSTON trial at the European Hematology Association Congress, Highlighting Clinical Potential in Relapsed/Refractory Multiple Myeloma

giovedì, 8 Giugno 2023
(Adnkronos) – FLORENCE, Italy, June 8, 2023 /PRNewswire/ — The Menarini Group (“Menarini”), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group,